摘要:
A disc brake that suppresses braking noises when a vehicle moves backward include an urging spring urging a friction pad toward a rotationally exiting side of a disc when the vehicle moves forward, the urging spring being arranged between a hook portion of the friction pad and a torque receiving portion of a carrier. The urging spring formed through bend of an elastic plate material has its spring constant that is set to be a small value to avoid resonance frequency causing noise where the base end side thereof is fixed to the hook portion of the backing plate while the top end side thereof elastically abuts to the torque receiving portion of the carrier. The urging spring is located at the position that is outside in the radial direction from the center position of the hook portion in its width direction.
摘要:
The invention relates to a pigment dispersion comprising: a condensate of or a salt between a polyallylamine and a polyester having a free carboxylic acid or the salt; a pigment derivative represented by the following general formula (1); a pigment; and an organic solvent, (P−X)−[N(R1, R2, R3, R4)]+ general formula (1) wherein p represents an organic dyestuff residue; X represents a sulfonic acid group or a carboxylic acid group; R1 represents an alkyl group having 5 to 20 carbon atoms; and R2, R3 and R4 each independently represents a hydrogen atom or an alkyl group having 1 to 20 carbon atoms.
摘要翻译:本发明涉及一种颜料分散体,其包含:聚烯丙胺与具有游离羧酸或其盐的聚酯之间的盐或其盐的缩合物; 由以下通式(1)表示的颜料衍生物; 颜料; 和有机溶剂<?in-line-formula description =“In-line Formulas”end =“lead”?>(PX)[N(R 1) ,R 2 R 3,R 3,R 4)] - 通式(1)&lt;&Sigma;&CenterDot;&CenterDot;&CenterDot; -formulae description =“In-line Formulas”end =“tail”?>其中p表示有机染料残留物; X表示磺酸基或羧酸基; R 1表示碳原子数5〜20的烷基, R 2,R 3和R 4各自独立地表示氢原子或碳原子数1〜20的烷基。
摘要:
A disc brake that suppresses braking noises when a vehicle moves backward include an urging spring urging a friction pad toward a rotationally exiting side of a disc when the vehicle moves forward, the urging spring being arranged between a hook portion of the friction pad and a torque receiving portion of a carrier. The urging spring formed through bend of an elastic plate material has its spring constant that is set to be a small value to avoid resonance frequency causing noise where the base end side thereof is fixed to the hook portion of the backing plate while the top end side thereof elastically abuts to the torque receiving portion of the carrier. The urging spring is located at the position that is outside in the radial direction from the center position of the hook portion in its width direction.
摘要:
The present invention relates to a compound of the formula [I]: wherein (a), in which —Y—, R4, R5 and R6 are4 R5 each as defined in the description, etc., R1 is hydrogen, halogen, lower alkyl, hydroxy, etc., R2 is hydrogen, lower alkyl or hydroxy(lower)alkyl, R3 is hydrogen or an amino protective group, 20R7 is hydrogen, lower alkyl, cyclo(lower)alkyl, lower R9 alkenyl, —Z—R9 or (b), in which —Z— is —0—, —S—, R9 —SO— or —SO2—, and each R9 is independently hydrogen, lower alkyl, cyclo(lower)alkyl, etc., and R8 is -D-E-R10, in which -D- is —CONHSO2— or —S02NHCO—, E is bond or lower alkylene, and R10 is halogen, cyano, carboxy, etc., or a prodrug thereof or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of ulcer, overactive bladder, and the like.
摘要:
A pigment dispersing agent of the formula (1) capable of providing a printing ink or a coating composition excellent in fluidity and dispersion stability and a dry coating excellent in gloss, a pigment composition containing the same and a pigment dispersion containing the same, wherein X1 is —NH—, —O—, —CONH—, —SO2NH—, —CH2NH—, —CH2NHCOCH2NH— or —X3—Y—X4—, X2 and X4 are —NH— or —O—, X3 is —CONH—, —SO2NH—, —CH2NH—, —NHCO— or —NHSO2—, Y is an alkylene group, an alkenylene group or an arylene group, Z is —SO3M or —COOM, R1 is a heterocyclic ring residue or an aromatic ring residue, Q is —O—R2, —NH—R2, a halogen group, —X1—R1 or —X2—Y-Z, R2 is a hydrogen atom, an alkyl group or an alkenyl group, and M is one equivalent of a monovalent to trivalent cation.
摘要:
The present invention relates to a compound formula[I]: wherein X is bond, —CH2—, —O— or —NH—, R1 and R12 are each independently hydrogen, halogen, lower alkyl, etc., R2 is hydrogen or optionally substituted lower alkyl, R3 is hydrogen or an amino protective group, R4, R5 and R6 are each independently hydrogen or optionally substituted lower alkyl, R7 is -Z-R13, in which Z is bond, etc., and R13 is carboxy, lower alkoxycarbonyl, (lower alkylsulfonyl)carbamoyl or lower alkanoylsulfamoyl, R8 is —Y—R9, in which Y is bond, —CH2—, —O—, —S—, etc., and R9 is hydrogen, lower alkyl, cyclo(lower)alkyl, etc., and R11 is hydrogen, lower alkyl, lower alkoxy, etc., or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of pollakiurea or urinary incontinence.
摘要:
The present invention relates to a compound formula[I]: wherein X is bond, —CH2—, —O— or —NH—, R1 and R12 are each independently hydrogen, halogen, lower alkyl, etc., R2 is hydrogen or optionally substituted lower alkyl, R3 is hydrogen or an amino protective group, R4, R5 and R6 are each independently hydrogen or optionally substituted lower alkyl, R7 is -Z-R13, in which Z is bond, etc., and R13 is carboxy, lower alkoxycarbonyl, (lower alkylsulfonyl)carbamoyl or lower alkanoylsulfamoyl, R8 is —Y—R9, in which Y is bond, —CH2—, —O—, —S—, etc., and R9 is hydrogen, lower alkyl, cyclo(lower)alkyl, etc., and R11 is hydrogen, lower alkyl, lower alkoxy, etc., or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of pollakiurea or urinary incontinence.
摘要:
The present invention relates to a compound of the formula [I]: wherein (a), in which —Y—, R4, R5 and R6 are4 R5 each as defined in the description, etc., R1 is hydrogen, halogen, lower alkyl, hydroxy, etc., R2 is hydrogen, lower alkyl or hydroxy(lower)alkyl, R3 is hydrogen or an amino protective group, 20R7 is hydrogen, lower alkyl, cyclo(lower)alkyl, lower R9 alkenyl, -Z-R9 or (b), in which -Z- is -0-, —S—, R9—SO— or —SO2—, and each R9 is independently hydrogen, lower alkyl, cyclo(lower)alkyl, etc., and R8 is -D-E-R , in which -D- is —CONHSO2— or —S02NHCO—, E is bond or lower alkylene, and R10 is halogen, cyano, carboxy, etc., or a prodrug thereof or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of ulcer, overactive bladder, and the like.